Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential

doi:10.3748/wjg.v29.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5374)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

276

WORD

HTML

3005

Figures (1-2)

438

Tables (1-4)

568

Sum=4331

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

240

Download

803

Sum=1043

Jan 7, 2023 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 7, 2023; 29(1): 1-18
Published online Jan 7, 2023. doi: 10.3748/wjg.v29.i1.1

Table 1 Dysregulation of microRNAs and oxaliplatin resistance in colorectal cancer

MiRNAs	Expression¹	Targets and pathways	Ref.
miR-135b-5p	↑	MUL1/ULK1	[49]
miR-454-3p	↑	PTEN	[50]
miR-19a	↑	PTEN/PI3K/AKT	[51]
miR-543	↑	PTEN/Akt/mTOR	[52]
miR-107	↑	CAB39/AMPK/mTOR	[53]
miR-503-5p	↑	PUMA	[54]
miR-744	↑	BIN1	[55]
miR-5000-3p	↑	USP49	[56]
miR-146b-5p	↑	WBSCR22	[57]
miR-19b-3p	↑	SMAD4	[58]
miR-1278	↓	-	[59]
miR-506	↓	Wnt/β-catenin	[60]
miR-200b-3p	↓	TUBB3	[61]
miR-122	↓	XIAP	[62]
miR-193a-5p	↓	CXCR4	[63]
miR-483-3p	↓	FAM171B	[64]
miR-325	↓	HSPA12B/PI3K/AKT/Bcl-2	[65]
miR-195-5p	↓	-	[66]
miR-497-5p	↓	-	[66]
miR-34a	↓	TGF-β/Smad4	[68]
miR-27b-3p	↓	-	[69]

¹Aberrant expression of miRNAs either up-regulated (↑) or down-regulated (↓) in CRC oxaliplatin resistance.

MiRNAs: MicroRNAs.

Table 2 Dysregulation of long non-coding RNAs and oxaliplatin resistance in colorectal cancer

LncRNAs	Expression¹	Targets and pathways	Ref.
GIHCG	↑	-	[82]
lncARSR	↑	-	[83]
HOTAIR	↑	miR-1277-5p/ZEB1	[85]
MALAT1	↑	MALAT1/miR-218/EZH2	[86]
MALAT1	↑	miR-324-3p/ADAM17	[88]
OIP5-AS1	↑	miR-137	[89]
Linc00152	↑	miR-193a-3p/ERBB4/AKT	[90]
CASC15	↑	miR-145/ABCC1	[92]
CBR3-AS1	↑	miR-145-5p	[93]
CRNDE	↑	miR-136/E2F1	[94]
LINC00460	↑	miR-149-5p/miR-150-5p/p53	[95]
KCNQ1OT1	↑	miR-34a/Atg4B	[96]
MIR155HG	↑	miR-650/Annexin A2	[91]
lnc-RP11-536 K7.3	↑	SOX2/HIF-1α/USP7	[97]
TUG1	↑	GATA6/BMP	[98]
LUCAT1	↑	UBA52/RPL40/MDM2/p53	[99]
PiHL	↑	EZH2/HMGA2/PI3K/Akt	[100]
ELFN1-AS1	↑	EZH2/DNMT3a/MEIS1	[102]
SNHG5	↑	STAU1	[103]
CCAT2	↑	BOP1/AURKA	[104]
NBAT-1	↓	WWC3/LATS1/YAP	[105]
MEG3	↓	-	[106]
MEG3	↓	miR-141/PDCD4	[107]
lnc-AP	↓	pep-AP/TALDO1	[108]
lncRNA PVT1	-	hsa-miR-297/GSTA2	[109]

¹Aberrant expression of lncRNAs either up-regulated (↑) or down-regulated (↓) in CRC oxaliplatin resistance.

LncRNAs: Long non-coding RNAs.

Table 3 Dysregulation of circular RNAs and oxaliplatin resistance in colorectal cancer

CircRNAs	Expression¹	Targets and pathways	Ref.
circPTK2	↑	miR-136-5P/YTHDF1	[122]
(hsa_circ_0003221)	↑	miR-136-5P/YTHDF1	[122]
circ_0032833	↑	miR-125-5p/MSI1	[123]
hsa_circ_0079662	↑	hsa-mir-324-5p/TNF-α/HOXA9	[124]
circHIPK3	↑	miR-637/STAT3/Bcl-2/Beclin1	[125]
Circular CCDC66	↑	PI3KK/p-DHX9	[126]
hsa_circ_32883/	↑	-	[127,128]
hsa_circ_0338	↑	-	[127,128]

¹Aberrant expression of circRNAs either up-regulated (↑) or down-regulated (↓) in CRC oxaliplatin resistance.

CircRNAs: Circular RNAs.

Table 4 Aberrant exosomal non-coding RNAs and their targets in the chemoresistance of colorectal cancer

Exosomal ncRNAs¹	Donor cells	Recipient cells	Targets and pathways	Ref.
miR-21↓	THLG-293T/LG-293T cells	CRC cells	-	[156]
miR-208b↑	CRC cells	T cells	PDCD4	[145]
miR-92a-3p↑	CAFs cells	CRC cells	FBXW7/MOAP1	[20]
miR-46146↑	CRC-R cells	CRC-S cells	PDCD10	[146]
miR-1915-3p↓	FHC cells	CRC cells	PFKFB3/USP2	[147]
lncRNA H19↑	CAFs cells	CRC cells	-	[141]
lncRNA CCAL↑	CAFs cells	CRC cells	HuR/β-catenin	[142]
cricN4BP2L2	CAFs cells	CRC cells	EIF4A3/PI3K/AKT/mTOR	[143]
ciRS-122↑	CRC-R cells	CRC-S cells	miR-122/PKM2	[148]
circ_0094343↓	NCM460 cells	CRC cells	miR-766-5p/TRIM67	[144]

¹Aberrant exosomal ncRNAs are either up-regulated (↑) or down-regulated (↓) in CRC oxaliplatin resistance. CRC-R cells and CRC-S cells represent oxaliplatin-resistant and oxaliplatin-sensitive cells, respectively.

ncRNAs: Non-coding RNAs; CRC: Colorectal cancer; CAFs: Cancer-associated fibroblasts.

Citation: Luo ZD, Wang YF, Zhao YX, Yu LC, Li T, Fan YJ, Zeng SJ, Zhang YL, Zhang Y, Zhang X. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential. World J Gastroenterol 2023; 29(1): 1-18
URL: https://www.wjgnet.com/1007-9327/full/v29/i1/1.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i1.1